Shaoliang Peng

Dr. Shaoliang Peng

National Supercomputing Center in Changsha, Hunan University, Changsha 410012, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in GigaScience
Verified
Journal Article
Open access
PDF file
RLRuibang Luo
Ruibang Luo
BLBinghang Liu
Binghang Liu
YXYinlong Xie
Yinlong Xie
ZLZhenyu Li
Zhenyu Li
WHWeihua Huang
Weihua Huang
JWJun Wang
Jun Wang
Background: There is a rapidly increasing amount of de novo genome assembly using next-generation sequencing (NGS) short reads; however, several big challenges remain to be overcome in order for this to be efficient and accurate. SOAPdenovo has been successfully applied to assemble many published genomes, but it still needs improvement in continuity, accuracy and coverage, especially in repeat regions. Findings: To overcome these challenges, we have developed its successor, SOAPdenovo2, which has the advantage of a new algorithm design that reduces memory consumption in graph construction, resolves more repeat regions in contig assembly, increases coverage and length in scaffold construction, improves gap closing, and optimizes for large genome. Conclusions: Benchmark using the Assemblathon1 and GAGE datasets showed that SOAPdenovo2 greatly surpasses its predecessor SOAPdenovo and is competitive to other assemblers on both assembly length and accuracy. We also provide an updated assembly version of the 2008 Asian (YH) genome using SOAPdenovo2. Here, the contig and scaffold N50 of the YH genome were ~20.9 kbp and ~22 Mbp, respectively, which is 3-fold and 50-fold longer than the first published version. The genome coverage increased from 81.16% to 93.91%, and memory consumption was ~2/3 lower during the point of largest memory consumption.

11 April 2018 in Interdisciplinary Sciences: Computational Life Sciences
Verified
Journal Article
Closed access
PDF file
YCYingbo Cui
Yingbo Cui
JXJiaming Xu
Jiaming Xu
MCMinxia Cheng
Minxia Cheng
XLXiangke Liao
Xiangke Liao
XZXiaoyu Zhang
Xiaoyu Zhang

14 February 2013 in Genome Biology
Verified
Journal Article
Open access
PDF file
WJWenlong Jia
Wenlong Jia
KQKunlong Qiu
Kunlong Qiu
MHMinghui He
Minghui He
PSPengfei Song
Pengfei Song
QZQuan Zhou
Quan Zhou
GGGuangwu Guo
Guangwu Guo
We have developed a new method, SOAPfuse, to identify fusion transcripts from paired-end RNA-Seq data. SOAPfuse applies an improved partial exhaustion algorithm to construct a library of fusion junction sequences, which can be used to efficiently identify fusion events, and employs a series of filters to nominate high-confidence fusion transcripts. Compared with other released tools, SOAPfuse achieves higher detection efficiency and consumed less computing resources. We applied SOAPfuse to RNA-Seq data from two bladder cancer cell lines, and confirmed 15 fusion transcripts, including several novel events common to both cell lines. SOAPfuse is available at http://soap.genomics.org.cn/soapfuse.html.

26 September 2018 in Briefings in Functional Genomics
Verified
Journal Article
Closed access
PDF file
ZZZhiqiang Zhang
Zhiqiang Zhang
YZYi Zhao
Yi Zhao
XLXiangke Liao
Xiangke Liao
WSWenqiang Shi
Wenqiang Shi
KLKenli Li
Kenli Li
XZXiaoyu Zhang
Xiaoyu Zhang
Omics, such as genomics, transcriptome and proteomics, has been affected by the era of big data. A huge amount of high dimensional and complex structured data has made it no longer applicable for conventional machine learning algorithms. Fortunately, deep learning technology can contribute toward resolving these challenges. There is evidence that deep learning can handle omics data well and resolve omics problems. This survey aims to provide an entry-level guideline for researchers, to understand and use deep learning in order to solve omics problems. We first introduce several deep learning models and then discuss several research areas which have combined omics and deep learning in recent years. In addition, we summarize the general steps involved in using deep learning which have not yet been systematically discussed in the existent literature on this topic. Finally, we compare the features and performance of current mainstream open source deep learning frameworks and present the opportunities and challenges involved in deep learning. This survey will be a good starting point and guideline for omics researchers to understand deep learning.

15 August 2021 in Journal of Raman Spectroscopy
Verified
Journal Article
Closed access
PDF file
LPLiangrui Pan
Liangrui Pan
PZPeng Zhang
Peng Zhang
CDChalongrat Daengngam
Chalongrat Daengngam
XZXiaoyu Zhang
Xiaoyu Zhang
MCMitchai Chongcheawchamnan
Mitchai Chongcheawchamnan

28 June 2021 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
DZDeshan Zhou
Deshan Zhou
Zhijian XuZhijian Xu
Zhijian Xu
WLWenTao Li
WenTao Li
XXXiaoLan Xie
XiaoLan Xie
XZXiaoyu Zhang
Xiaoyu Zhang
Predicting new drug–target interactions is an important step in new drug development, understanding of its side effects and drug repositioning. Heterogeneous data sources can provide comprehensive information and different perspectives for drug–target interaction prediction. Thus, there have been many calculation methods relying on heterogeneous networks. Most of them use graph-related algorithms to characterize nodes in heterogeneous networks for predicting new drug–target interactions (DTI). However, these methods can only make predictions in known heterogeneous network datasets, and cannot support the prediction of new chemical entities outside the heterogeneous network, which hinder further drug discovery and development. To solve this problem, we proposed a multi-modal DTI prediction model named ‘MultiDTI’ which uses our proposed joint learning framework based on heterogeneous networks. It combines the interaction or association information of the heterogeneous network and the drug/target sequence information, and maps the drugs, targets, side effects and disease nodes in the heterogeneous network into a common space. In this way, ‘MultiDTI’ can map the new chemical entity to this learned common space based on the chemical structure of the new entity. That is, bridging the gap between new chemical entities and known heterogeneous network. Our model has strong predictive performance, and the area under the receiver operating characteristic curve of the model is 0.961 and the area under the precision recall curve is 0.947 with 10-fold cross validation. In addition, some predicted new DTIs have been confirmed by ChEMBL database. Our results indicate that ‘MultiDTI’ is a powerful and practical tool for predicting new DTI, which can promote the development of drug discovery or drug repositioning. Python codes and dataset are available at https://github.com/Deshan-Zhou/MultiDTI/. Supplementary data are available at Bioinformatics online.